Filter
Exclude
Time range
-
Near
Dr Namrah Siddiq @YaleHemOnc presenting at @YaleCancer Fellowship Research Day on new technologies to predict response to neoadjuvant chemotherapy #bcsm
0
0
0
0
Adriana Lecuona retweeted
Sign up for our email list to have medical insight, emotional support, personal stories, and more delivered to your inbox weekly: bit.ly/3677LfV #bcsm
0
3
0
4
With popular demand and post #ASCO22 data, I think #bcsm has to be next, we did one on #melanoma before here:
Melanoma treatment algorithm. Credit @ADesaiMD. This algorithm is a little different. Download the pdf version below and the words in blue are hyperlinks to the trials supporting the treatments. dropbox.com/s/i6f0cimi299jsv…
Show this thread
0
0
0
1
NCI Media Relations retweeted
In the latest NCI Minute, a report on the promising results of an #immunotherapy #ClinicalTrial for some patients with metastatic breast cancer. #BCSM
0
5
1
6
506
Sue Corralz, SPHR retweeted
Looking forward to this poster presentation at #ASCO22 Metastatic Lobular Patients need to know which treatments are effective in ILC Thank you @JAMouabbi for this imprtant work. @LobularBCA @LPseattle @double_whammied #bcsm
The breast cancer subtypes invasive lobular carcinoma and ductal carcinoma are often grouped. Dr. Jason Mouabbi explains why invasive lobular carcinoma should be studied separately. He will share new treatment insights at #ASCO22: fal.cn/3oXkd @JAMouabbi #EndCancer
0
2
0
4
☀️ #FF - I'm always looking for new and interesting follows on here! Who's feed have you been frequenting lately? #AYACSM #BCSM #CancerResearch #AcademicTwitter #PhDVoice #PhDLife #BTSM #LCSM
0
0
0
3
Linda Holden retweeted
Black women and men represent only 4% to 6% of patients in all cancer clinical trials. So why are participation numbers so low, and what can be done about it? Read our findings which identify 4 actions to improve participation: mbca.me/3NbOQEv #BCSM #MBCResearch
0
4
2
9
Azra AI retweeted
"Just being able to see colleagues in person and hear about the latest science really reinvigorates my energy and my intellectual curiosity," says @TarahBallinger in looking ahead to #ASCO22 sessions on #metastatic #breastcancer. #bcsm
1
4
0
26
5,548
Lobular Breast Cancer Alliance retweeted
"it is possible that #lobular #breastcancer with #CDH1 germline mutations are an independent inherited syndrome" (from hereditary diffuse gastric cancer) 👇👇👇 #HDGC @FacingOurRisk @lobularBCA @oesterreichs @ChristineDesme2 #bcsm
0
1
0
3
Lobular Breast Cancer Alliance retweeted
Great Primer on #Lobular #breastcancer, its differences from more common Ductal/NST #BC and opportunities to improve therapies for patients needing more #ILC specific research 👇👇👇 @BCRFcure @SusanGKomen #OncTwitter #OncoAlert #bcsm Thx @JAMouabbi @MDAndersonNews
The breast cancer subtypes invasive lobular carcinoma and ductal carcinoma are often grouped. Dr. Jason Mouabbi explains why invasive lobular carcinoma should be studied separately. He will share new treatment insights at #ASCO22: fal.cn/3oXkd @JAMouabbi #EndCancer
0
1
0
4